Drastic Reduction in Time to Controlled Viral Load in People With Human Immunodeficiency Virus in France, 2009–2019: A Longitudinal Cohort Study

Archive ouverte

Cuzin, Lise | Morisot, Adeline | Allavena, Clotilde | Lert, France | Pugliese, Pascal | Chirouze, C | Babre, O | Bouiller, K | Bozon, F | Brunel, A | Chevalier, E | Hustache-Mathieu, L | Lagoutte, J | Lepiller, Q | Marty-Quinternet, S | Muret, P | Rosolen, B | Tissot, N | Jaffuel, S | Jacomet, C | Aumeran, C | Baud, O | Brebion, A | Corbin, V | Goncalvez, E | Henquell, C | Laurichesse, H | Lesens, O | Mazzocolin, D | Mirand, A | Mrozek, N | Theis, C | Vidal, M | Lamaury, I | Bissuel, F | Boulard, F | Curlier, E | Fabre, I | Halley, E | Herrmann-Storck, C | Guillou, C Le | Markowicz, S | Marquet, M | Ouissa, R | Receveur, M | Reltien, J | Roger, P | Tressieres, B | Merrien, D | Bollangier, O | Boucher, D | Guimard, T | Laine, L | Leautez, S | Morrier, M | Perré, P | Point, P | Faucher, J | Cypierre, A | Ducroix-Roubertou, S | Durox, H | Genet-Villeger, C | Pascual, J | Pinet, P | Rogez, S | Woillard, J | Cotte, L | Ader, F | Alfaiate, D | Becker, A | Boibieux, A | Brochier, C | Brunel-Dalmas, F | Cannesson, O | Chiarello, P | Chidiac, C | Conrad, A | Degroodt, S | Ferry, T | Godinot, M | Icard, V | Livrozet, J | Makhloufi, D | Perpoint, T | Perry, M | Pouderoux, C | Roux, S | Trabaud, M | Triffault-Fillit, C | Valour, F | Ravaux, I | Ménard, A | Aherfi, S | Amrane, S | Belkhir, A | Colson, P | Dhiver, C | Martin-Degioanni, M | Meddeb, L | Mokhtari, M | Motte, A | Tissot-Dupont, H | Toméi, C | Poizot-Martin, I | Brégigeon, S | Ducassou, M | Galie, S | Ivanova, A | Jaquet, I | Laroche, H | Obry-Roguet, V | Orticoni, M | Ressiot, E | Ritleng, A | Rojas-Rojas, T | Zaegel-Faucher, O | Cabié, A | Abel, S | Bavay, J | Bigeard, B | Cabras, O | Dupin de Majoubert, R | Fagour, L | Guitteaud, K | Lehoux, M | Montagnac, C | Pierre-François, S | Rome, K | Turmel, J | Reynes, J | Atoui, N | Bistoquet, M | Delaporte, E | Moing, V Le | Lejeune, J | Makinson, A | Meftah, N | Merle de Boever, C | Montes, B | Ferrer, a Montoya | Tuaillon, E | Lefèvre, B | André, M | Baronnet, G | Bevilacqua, S | Boyer, L | Bouillon, M | Charmillon, A | Delestan, M | Frentiu, E | Goehringer, F | Hénard, S | Jeanmaire, E | Rabaud, C | Radjabaly-Mandjee, A | Raffi, F | André-Garnier, E | Asquier-Khati, A | Billaud, E | Biron, C | Bonnet, B | Bouchez, S | Boutoille, D | Brunet-Cartier, C | Cavellec, M | Deschanvres, C | Ferré, V | Gaborit, B | Grégoire, A | Grégoire, M | Jovelin, T | Lefebvre, M | Lecomte, R | Mahot, R | Morineau, P | Paredes, E | Reliquet, V | Sécher, S | Soria, A | Bréaud, S | Buscot, M | Carles, M | Chirio, D | Cua, E | Dellamonica, P | Demonchy, E | de Monte, A | Durant, J | Ferrando, S | Garraffo, R | Michelangeli, C | Naqvi, A | Perbost, I | Pradier, C | Prouvost-Keller, B | Risso, K | Touitou, I | Viot, A | Wehrlen-Pugliese, S | Hocqueloux, L | Gubavu, C | Legros, V | Peira, F | Prazuck, T | Rzepecki, V | Sève, A | Cheret, A | Barrail-Tran, A | Castro, A | Colarino, R | Goujard, C | Jaureguiberry, S | Quertainmont, Y | Teicher, E | Joly, V | Charpentier, C | Descamps, D | Digumber, M | Gervais, A | Ghosn, J | Julia, Z | Landman, R | Lariven, S | Gac, S Le | Louni, F | Peytavin, G | Rioux, C | Yazdanpanah, Y | Duvivier, C | Amazzough, K | Benabdelmoumen, G | Bossi, P | Cessot, G | Charlier, C | Consigny, P | Gomes-Pires, E | Jidar, K | Lafont, E | Lanternier, F | Lortholary, O | Louisin, C | Lourenco, J | Melenotte, C | Parize, P | Pouvaret, A | Rouzaud, C | Serris, A | Touam, F | Katlama, C | Agher, R | Blanc, C | Dudoit, Y | Hamani, N | Qatib, N | Qzaibri, I | Lenclume, L | Palich, R | Schneider, L | Seang, S | Tubiana, R | Valantin, M | Bani-Sadr, F | Bermejo, M | Berger, J | Demotier, S | Hentzien, M | Julien, G | Kmiec, I | Lambert, D | Marty, H | N’guyen, Y | Romaru, J | Arvieux, C | Baldeyrou, M | Benezit, F | Chapplain, J | Dupont, M | Duthé, J | Lebot, A | Lemaitre, F | Maillard, A | Morlat, C | Patrat-Delon, S | Poisson-Vannier, M | Pronier, C | Revest, M | Sinteff, J | Souala, F | Tattevin, P | Gagneux-Brunon, A | Botelho-Nevers, E | Frésard, A | Lucht, F | Ronat, V | Rey, D | Cheneau, C | Bernard-Henry, C | de Mautort, E | Fafi-Kremer, S | Fischer, P | Gantner, P | Mélounou, C | Partisani, M | Delobel, P | Alvarez, M | Biezunski, N | Debard, A | Delpierre, Cyrille | Garnier, C | Gaube, G | Lelièvre, L | Marcel, M | Martin-Blondel, G | Piffaut, M | Porte, L | Saune, K | Robineau, O | Aïssi, E | Ajana, F | Alcaraz, I | Alidjinou, E | Baclet, V | Bocket, L | Boucher, A | Derdour, V | Gilbert, M | Huleux, T | Lafon-Desmurs, B | Meybeck, A | Pradier, M | Tetart, M | Thill, P | Valette, M | Viget, N | Corvaisier, G

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Abstract Background Aspirational targets to end AIDS by 2030 include having 95% of people with human immunodeficiency virus (HIV; PWH) diagnosed, 95% treated, and 95% with controlled viral load (VL). Our objective was to describe, using a large French prospective cohort, the median transition times through the cascade of care between 2009 and 2019. Methods We analyzed patients whose first HIV diagnosis was made between 1 January 2009 and 31 December 2019. Using the Kaplan–Meier method, we estimated the time to linkage to care (from HIV diagnosis to first biological assessment), to treatment (date of first antiretroviral therapy [ART] prescription), and to controlled VL (first value <200 copies/mL). Analyses were disaggregated by time periods and patients' characteristics. Censoring date was 31 December 2021. Results Among the 16 864 patients linked to care since 2009, the median [Q1; Q3] time from HIV diagnosis to controlled VL decreased from 254 [127–745] to 73 [48–132] days in 2009–2011 and 2018–2019, respectively. Transition times from linkage to care to first ART decreased from 67 [17; 414] in 2009–2011 to 13 [5; 26] days in 2018–2019, and from ART to controlled VL from 83 [35; 130] in 2009–2011 to 38 [28; 90] days in 2018–2019. Differences were observed depending on patients' characteristics. Conclusions We describe drastic reductions in transition time through the cascade of care, allowing reduction in the transmission period following each new infection. Delayed diagnosis remains the main obstacle to ending AIDS in the next decade.

Consulter en ligne

Suggestions

Du même auteur

Low-level viral loads and virological failure in the integrase strand transfer era

Archive ouverte | Cuzin, Lise | CCSD

International audience. Objectives To analyse the occurrence of virological failure (VF) in patients starting ART with an integrase strand transfer inhibitor (INSTI)-based regimen in recent years, in relation with p...

Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study

Archive ouverte | Perfezou, Pascale | CCSD

International audience. Background: Two-drug regimens based on integrase strand transfer inhibitors (INSTIs) and boosted PIs have entered recommended ART. However, INSTIs and boosted PIs may not be suitable for all ...

Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012–2018

Archive ouverte | Pradat, Pierre | CCSD

International audience. Abstract Background The arrival of highly effective, well-tolerated, direct-acting antiviral agents (DAA) led to a dramatic decrease in hepatitis C virus (HCV) prevalence. Human immunodeficie...

Chargement des enrichissements...